Analysis of Chlamydia pneumoniae-specific oligoclonal bands in multiple sclerosis and other neurologic diseases

D Franciotta1, E Zardini, R Bergamaschi

  • 1Laboratory of Neuroimmunology, IRCCS, Foundation Neurological Institute C. Mondino, University of Pavia, Pavia, Italy. diego.franciotta@mondino.it

Abstract

Insights

Chlamydia pneumoniae-specific oligoclonal bands (OCBs) were found in a small number of multiple sclerosis (MS) patients. This suggests a potential role in the broader immune response within MS.

Area of Science:

  • Neuroimmunology
  • Infectious Immunology

Background:

  • Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system.
  • The role of infectious agents, such as Chlamydia pneumoniae, in MS pathogenesis is under investigation.

Purpose of the Study:

  • To investigate the presence and specificity of Chlamydia pneumoniae-specific oligoclonal bands (OCBs) in serum and cerebrospinal fluid (CSF) of MS patients.
  • To determine if these OCBs are specific to MS or also present in other neurological conditions.

Main Methods:

  • Serum and CSF samples were analyzed from patients with relapsing-remitting MS, other inflammatory/non-inflammatory neurological diseases, and healthy controls.
  • Affinity immunoblotting was used to detect C. pneumoniae-specific IgG OCBs after agarose isoelectric focusing.

Main Results:

  • Chlamydia pneumoniae-specific OCBs were detected in 5 out of 56 MS patients.
  • These specific OCBs were also found in 3 out of 18 patients with other inflammatory neurological diseases.

Conclusions:

  • Intrathecal production of C. pneumoniae-specific oligoclonal IgG occurs in a subset of MS patients.
  • This reactivity to C. pneumoniae is likely a component of a broader, polyspecific immune response in MS.